AHR
36 programs · 36 companies
Programs
36
Companies
36
Active Trials
20
Targeting AHR
| Drug | Company | Phase | MOA | Indications |
|---|---|---|---|---|
| PFE-2901 | Pfizer | Phase 2 | SMACLL | |
| AZN-1715 | AstraZeneca | Phase 3 | SMAPsoriasis | |
| BAY-6520 | Bayer | Phase 2 | FSGS | |
| Semasacituzumab | Jazz Pharma | Phase 2 | GBMPNH | |
| Doxalemzoparlimab | Nuvalent | Approved | WMADHD | |
| CRS-184 | CRISPR Therapeutics | Phase 1/2 | PompeMelanoma | |
| Terazumab | Recursion | Phase 3 | MSHemophilia A | |
| DAW-5540 | Day One Bio | Phase 2 | ALSGastric Ca | |
| Liralucimab | Arcturus | Phase 2 | GISTPompe | |
| Mavulucimab | CSL Limited | NDA/BLA | PompeThymoma | |
| ASL-9777 | Aslan Pharma | Phase 2 | UC | |
| MAY-IIT-516 | Mayo Clinic | Phase 3 | ALS | |
| NIA-IIT-611 | NIAID | Phase 2 | Crohn's | |
| CAM-IIT-240 | CAMS | NDA/BLA | ET | |
| UCS-IIT-265 | UCSF | Phase 3 | Thymoma | |
| Zoriosocimab | Asklepios Bio | Approved | MGMDD | |
| Zanulemzoparlimab | Morphic Ther (Lilly) | Phase 3 | FTDPBC | |
| WIN-5410 | Windtree Therapeutics | NDA/BLA | HCC | |
| Kemamavacamten | Celgene (BMS) | Preclinical | MCLBCC | |
| SHI-2989 | Shire (Takeda) | Phase 2 | ADPKDGA | |
| Nidatenlimab | ABL Bio | Approved | BCC | |
| Darasertib | MiNT Ther | Phase 1/2 | Migraine | |
| TRE-5650 | Treeline | Phase 1/2 | Urothelial CaCKD | |
| Niraglumide | Deciphera | Preclinical | CMLPancreatic Ca | |
| BIO-5105 | Biocon | Phase 3 | NMOSD | |
| Datotapinarof | Aurobindo | Phase 1 | Thymoma | |
| LAU-4167 | Laurus Labs | NDA/BLA | SCDFSGS | |
| TRI-2500 | Trillium (Pfizer) | Phase 1/2 | WilmsCeliac | |
| Ivomavacamten | Exact Sciences | Phase 1/2 | FabryPSP | |
| SUV-4226 | Suven Pharma | Phase 3 | Melanoma | |
| Tixalucimab | Ache Laboratorios | Approved | MG | |
| BIO-IIT-877 | Bio-Manguinhos | Preclinical | SCLC | |
| Nidaratamab | Mega Lifesciences | Preclinical | CF | |
| CAM-IIT-192 | CAMS Peking Union | Phase 2 | ALS | |
| IDX-785 | IDEXX Laboratories | Phase 1 | Crohn's | |
| DNA-3921 | Ginkgo Bioworks | NDA/BLA | PsoriasisRett |